Delivery Order SPE2DB20D3505-SPE2DB23FT8W2
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $50,404.92 for the supply of ENBREL 50 MG/ML SURECLICKML. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of March 7, 2024. This DO is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $59,641.38 for the medical product ENBREL 50 MG/ML SURECLICK ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of March 2, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,158.98 for the supply of ENBREL 50 MG/ML SURECLICK. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating full and open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $23,180.97, is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of February 27, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,352.40 for the pharmaceutical product ENBREL 50 MG/ML SURECLICK. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on October 27, 2021, with an ultimate completion date of October 28, 2021. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
- This federal contract award, valued at $8,519.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product, to support military healthcare programs. The contract has a completion date of February 27, 2024, and is structured as a firm fixed-price delivery order. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of ENBREL 50 MG/ML SURECLICK medication. The $16,801.64 firm fixed-price contract has a completion date of February 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $17,765.37, is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order, with a completion date of January 29, 2024. The contract was awarded on January 26, 2024, and there was no set-aside designation utilized. Amerisourcebergen Drug Corp is a major...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,467.74 firm fixed-price delivery order is for the supply of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product. The contract has a completion date of February 12, 2024 and was awarded on February 9, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $8,400.82 for Enbrel 50 mg/ml SureClick medication. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 26, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) worth...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FT8W2Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,831.96 for the supply of ENBREL 50 MG/ML SURECLICKML. The contract, awarded by the Defense Logistics Agency (DLA), has a completion date of March 27, 2023 and is a firm fixed-price delivery order. The contract is not designated with a set-aside status. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 3/24/23 |